Wound Care: Mediators of Wound Healing

Growth Factors & Cytokines

Colony-Stimulating Factors

  • Macrophage Colony-Stimulating Factor (M-CSF)
    • Stimulates Hematopoietic Stem Cell Differentiation into Macrophages
  • Granulocyte Colony-Stimulating Factor (G-CSF)
    • Stimulates Hematopoietic Stem Cell Differentiation into Granulocytes (Neutrophils, Eosinophils and Basophils)
  • Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF)
    • Stimulates Hematopoietic Stem Cell Differentiation into Granulocytes (Neutrophils, Eosinophils and Basophils) & Monocytes/Macrophages

Transforming Growth Factors

  • Transforming Growth Factor Alpha (TGF-α)
    • Produced by Macrophages, Brain Cells & Keratinocytes
    • Induces Epithelial Development – Similar to EGF
  • Transforming Growth Factor Beta (TGF-β)
    • Produced by Macrophages and All Leukocytes
    • Anti-Inflammatory Effects:
      • Regulates Lymphocyte Proliferation, Differentiation & Survival
      • Inhibits Synthesis of Proinflammatory Cytokines
      • Inhibits Function of Natural Killer Cells, Dendritic Cells & Macrophages

Other Growth Factors

  • Fibroblastic Growth Factor (FGF)
    • Produced by Macrophages
    • Numerous Functions in Regulating Cell Proliferation, Migration & Differentiation
  • Epidermal Growth Factor (EGF)
    • Secreted by Salivary Glands
    • Stimulates Growth of Epidermal & Epithelial Cells
  • Vascular Endothelial Growth Factor (VEGF)
    • Promotes Angiogenesis
  • Platelet Derived Growth Factor (PDGF)
    • Secreted by Platelets
    • Attracts & Activates Inflammatory Cells & Fibroblasts
    • Promotes Wound Healing

Cytokines

  • Tumor Necrosis Factor Alpha (TNF-α)
    • Produced by Macrophages
    • Increases Adhesion & Coagulation
    • Activates Neutrophils & Macrophages
    • Causes Cachexia in Cancer Patients
  • Erythropoietin (EPO)
    • Secreted in the Kidney Due to Cellular Hypoxia
      • Fetal Production Primarily in the Liver
    • Stimulates Erythropoiesis (RBC Development)

Interleukins

  • IL-1
    • Strong Proinflammatory Effects
    • Causes Fever
      • Increased Prostaglandin E2 in Hypothalamus Raises Thermal Set-Point
      • NSAIDs Decrease Fever by Lowering PGE2 Levels
    • Activates Helper T Cells
  • IL-2
    • Released by Helper T Cells
    • Stimulates Differentiation/Maturation of Cytotoxic T Cells
  • IL-3
    • Stimulates Hematopoietic Stem Cell Differentiation & Proliferation
    • Causes Mast Cell Growth & Histamine Release
  • IL-4
    • Released by Helper T Cells
    • Stimulates Differentiation/Maturation of B Cells into Plasma Cells
  • IL-5
    • Overproduction Activates Eosinophils (Induces Allergies and Asthma)
  • IL-6
    • Stimulates Hepatic Acute Phase Response (Increased CRP & Amyloid A)
    • Stimulates Hematopoietic Stem Cell Differentiation
    • Stimulates Differentiation of B Cells into Plasma Cells & Plasma Cell Antibody Secretion
  • IL-7
    • Induces Differentiation & Proliferation of Lymphoid Progenitor Cells
    • Increases Proinflammatory Cytokines
  • IL-8
    • PMN Chemotaxis & Angiogenesis
  • IL-9
    • Released by Helper T Cells
    • Potentiates Select Ig Cells
  • IL-10
    • Inhibits Inflammatory Response

Impediments to Wound Healing

Tissue Factors

  • Wound Hypoxia & Edema
  • Dry Tissue/Desiccation (Wet-to-Dry Dressings Can Worsen)
  • Infection
  • Necrotic Tissue or Debris
  • Presence of Foreign Objects

Medical Factors

  • Malignancy
  • Diabetes/Hyperglycemia – Poor Leukocyte Chemotaxis
  • Smoking
  • Ischemia – Arterial Disease, etc.

Nutrition

  • Vitamin/Mineral Deficiency
  • Malnutrition (Albumin < 3.0)
    • Prolongs the Inflammatory Phase

Medications

  • Anti-Inflammatory Medication
  • Steroids – Inhibit Macrophage & Neutrophil Recruitment
    • Vitamin A Counteracts (Retinoids)

Chemotherapy

  • Effects:
    • Inhibit Inflammation
    • Inhibit Angiogenesis
    • Inhibits Cell Metabolism & Division
    • Inhibit Fibroblast Proliferation & Collagen Production
  • Timing of Surgery After Neoadjuvant Chemotherapy:
    • Low Effect After 14 Days
    • No Effects After 6 Months
    • Optimal Timing: 4-8 Weeks
      • Decreased Complete Pathologic Response After 8 Weeks (Specifically for Breast Cancer)

Radiation Therapy

  • Effects:
    • Cellular Depletion
    • Stromal Cell Dysfunction
    • Aberrant Collagen Deposition
    • Microvascular Damage
  • Timing:
    • Neoadjuvant/Preoperative Radiation: Effects
      • Effects Can Be Permanent
    • Adjuvant/Postoperative Radiation: No Effect
  • Preoperative Dosing:
    • < 300 cGy: No Significant Effect
    • > 1,000 cGy: Retards
    • > 4,500 cGy: Significantly Retards